Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell) (Beijing Tiantan Biological Products))

口服I型III型脊髓灰质炎减毒活疫苗(人二倍体细胞) （北京天坛生物制品）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePoliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell) (Beijing Tiantan Biological Products))
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Tiantan Biological Products Corporation Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Tiantan Biological Products Corporation Ltd
Active IndicationsN/A
Inactive IndicationsPoliomyelitis

Other Information

ATC CodeN/A
Related LinksN/A